Current Research Studies - Heart & Vascular
The following list contains clinical studies in which the OSF HealthCare Cardiovascular Institute is enrolling patients.
For questions or to enroll, please contact our research staff at (309) 589-1930 in the Peoria area and (815) 395-9181 in Rockford.
PRESERVED HF - Effects of dapagliflozin on biomarkers, symptoms and functional status in patients with Type 2 diabetes or pre-diabetes, and PRESERVED ejection fraction Heart Failure
Summary: A study to evaluate the effects of Dapagliflozin on biomarkers, symptoms and functional status in patients with Type II Diabetes or pre-diabetes, and preserved Ejection Fraction Heart Failure.
Investigator: Barry Clemson
Location: OSF HealthCare Cardiovascular Institute, Peoria, Illinois
Contact: Stephanie Hillis, (309) 589-1934, email@example.com